SMTL ID : 5hib.1

EGFR kinase domain mutant "TMLR" with a pyrazolopyrimidine inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.85 Å

Oligo State

monomer

Ligands

1 x 63M: N-tert-butyl-5-{[(1-methyl-1H-pyrazol-5-yl)sulfonyl]amino}pyrazolo[1,5-a]pyrimidine-3-carboxamide(Non-covalent)

63M.1: 17 residues within 4Å: Chain A: L.25, G.26, F.30, V.33, A.50, K.52, E.69, C.82, M.97, Q.98, L.99, M.100, R.148, N.149, L.151, T.161, D.162 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:F.30, A:V.33, A:L.151, A:L.151 Hydrogen bonds: A:M.100, A:D.162

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Foster, S.A. et al., Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2. Cancer Cell (2016)

Release Date

2016-04-06

Peptides

Epidermal growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Epidermal growth factor receptor

Related Entries With Identical Sequence